Physical stability of crystal hydrates and their anhydrates in the presence of excipients

Journal of Pharmaceutical Sciences

Volumn 95, Issue 2, 2006, Pages 446-461

  Salameh, Adnan K ^a   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Dehydration; Excipients; Hydrate; Hydration; Kinetics; Relative humidity; Transformation

Indexed keywords

CARBAMAZEPINE; CITRIC ACID; EXCIPIENT; LACTOSE; MANNITOL; MICROCRYSTALLINE CELLULOSE; POVIDONE; SUCROSE; THEOPHYLLINE; XYLITOL;

ARTICLE; CHEMICAL COMPOSITION; CRYSTAL; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; EXPOSURE; HUMIDITY; HYDRATION; KINETICS; MICROSCOPY; MODEL; MONITORING; PHASE TRANSITION; RAMAN SPECTROMETRY; SOLID STATE; VAPOR; X RAY POWDER DIFFRACTION;

EID: 32644434551     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20532     Document Type: Article

References (36)

1. Zografi G. 1988. States of water associated with solids. Drug Dev Ind Pharm 14:1905-1926.
2. Ahlneck C, Zografi G. 1990. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm 62:87-95.
3. Zografi G, Hancock BC. 1994. Water-solid interactions in pharmaceutical systems. In: Proceedings of 53rd International Congress of Pharmaceutical Sciences, Tokyo, JA.
4. Khankari RK, Grant DJW. 1995. Pharmaceutical hydrates. Thermochim Acta 248:61-79.
5. Morris KR, Rodriguez-Hornedo N. 1993. Hydrates. In: Swarbrick J, Boylan JC, editors. Encyclopedia of pharmaceutical technology, 1st edn. New York, Basel, Hong Kong: Marcel Dekker, Inc. pp 393-440.
6. Stahl HP. 1980. The problems of drug interactions with excipients. In: Braimer DD, editor. Towards better safety of drugs and pharmaceutical products. Amsterdam/New York: Elsevier/North-Holland Biomedical Press. pp 265-280.
7. Kontny MJ, Zografi G. 1995. Sorption of water by solids. In: Brittain HG, editor. Physical characterization of pharmaceutical solids. New York: Marcel Dekker, Inc. pp 387-418.
8. Otsuka M, Kaneniwa N, Kawakami K, Umezawa O. 1990. Effect of surface characteristics of theophylline anhydrate powder on hygroscopic stability. J Pharm Pharmacol 42:606-610.
9. Zhu H, Yuen C, Grant DJ. 1996. Influence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase. Part 1. Theophylline. Int J Pharm 135:151-160.
10. Ticehurst MD, Storey RA, Claire W. 2002. Application of slurry bridging experiments at controlled water activities to predict the solid-state conversion between anhydrous and hydrated forms using theophylline as a model drug. Int J Pharm 247:1-10.
11. Heidemann DR, Jarosz PJ. 1991. Preformulation studies involving moisture uptake in solid dosage forms. Pharm Res 8:292-297.
12. Otsuka M, Matsuda Y. 1994. The effect of humidity on hydration kinetics of mixtures of nitrofurantoin anhydride and diluents. Chem Pharm Bull 42:156-159.
13. Airaksinen S, Jorgensen A, Rantanen J, Yliruusi J, et al. 2003. Effects of excipients on hydrate formation in wet masses containing theophylline. J Pharm Sci 92:516-528.
14. Kesavan JG, Peck GE. 1996. Solid-state stability of theophylline anhydrous in theophylline anhydrous-polyvinylpyrrolidone physical mixtures. Drug Dev Ind Pharm 22:189-199.
15. Nyqvist H. 1983. Saturated salt solutions for maintaining specified relative humidities. Int J Pharm Tech Prod Mfr 4:47-48.
16. Kontoyannis CG, Bouropoulos NC, Koutsoukos PG. 1997. Use of Raman spectroscopy for the quantitative analysis of calcium oxalate hydrates - Application for the analysis of urinary stones. Appl Spectrosc 51:64-67.
17. Taylor LS, Zografi G. 1998. Quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res 15:755-761.
18. Phadnis NV, Suryanarayanan R. 1997. Polymorphism in anhydrous theophylline-Implications on the dissolution rate of theophylline tablets. J Pharm Sci 86:1256-1263.
19. Grzesiak AL, Lang MD, Kim K, Matzger AJ. 2003. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci 92:2260-2271.
20. McMahon LE, Timmins P, Williams AC, York P. 1996. Characterization of dihydrates prepared from carbamazepine polymorphs. J Pharm Sci 85:1064-1069.
21. Galwey AK. 2000. Structure and order in thermal dehydrations of crystalline solids. Thermochim Acta 355:181-238.
22. Levine H, Slade L. 1992. Glass transitions in foods. In: Schwartzberg HG, Harted RW, editors. Physical chemistry of foods. NY, Basel, Hong Kong: Marcel Dekker, Inc. pp 83-221.
23. Hancock BC, Zografi G. 1997. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86:1-12.
24. Taylor LS, Langkilde FW, Zografi G. 2001. Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. J Pharm Sci 90:888-901.
25. Devarakonda S, Evans JMB, Lee AY, Myerson AS. 2004. Molecular dynamics study of the interactions of ice inhibitors on the ice {001} surface. Langmuir 20:5353-5357.
26. Larsen R, Knight CA, Sloan ED. 1998. Clathrate hydrate growth and inhibition. Fluid Phase Equilib 151:353-360.
27. Kvamme B, Huseby G, Forrisdahl OK. 1997. Molecular dynamics simulations of PVP kinetic inhibitor in liquid water and hydrate/liquid water systems. Mol Phys 90:979-991.
28. Sakaguchi H, Ohmura R, Mori YH. 2003. Effects of kinetic inhibitors on the formation and growth of hydrate crystals at a liquid-liquid interface. J Cryst Growth 247:631-641.
29. Doherty WOS, Fellows CM, Gorjian S, Senogles E, Cheung WH. 2004. Inhibition of calcium oxalate monohydrate by poly(acrylic acid)s with different end groups. J Appl Polym Sci 91:2035-2041.
30. Bühler V. 2001. Kollidon. Polyvinylpyrrolidone for the pharmaceutical industry, 6th edn. Ludwigshafen: BASF.
31. Haaf F, Sanner A, Straub F. 1985. Polymers of n-vinypyrrolidone: Synthesis, characterization and uses. Polym J 17:143-152.
32. Raith K, Kuhn AV, Rosche F, Wolf R, Neubert RHH. 2002. Characterization of povidone products by means of C-13-NMR, MALDI-TOF, and electrospray mass spectrometry. Pharm Res 19:556-560.
33. Dormidontova EE. 2004. Influence of end groups on phase behavior and properties of PEO in aqueous solutions. Macromolecules 37:7747-7761.
34. Ando H, Watanabe S, Ohwaki T, Miyake Y. 1985. Crystallization of excipients in tablets. J Pharm Sci 74:128-131.
35. Dobson RL. 1987. Protection of pharmaceutical and diagnostic products through desiccant technology. J Pack Technol 1:127-135.
36. Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. 2001. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm 225:49-62.